The importance of science communication in cancer research: an interview with Martin Christlieb.


Journal

Future oncology (London, England)
ISSN: 1744-8301
Titre abrégé: Future Oncol
Pays: England
ID NLM: 101256629

Informations de publication

Date de publication:
Jul 2019
Historique:
pubmed: 30 6 2018
medline: 15 2 2020
entrez: 30 6 2018
Statut: ppublish

Résumé

I trained as a chemist, studying for a PhD at the University of Cambridge. After I left Cambridge, I undertook postdoctoral appointments at Stanford and Oxford. These appointments led me into metal chemistry, initially using the metals as reagents, and finally using metal atoms as the key atom in a series of compounds designed to be radiolabeled markers of tumor hypoxia for positron emission tomography (PET) imaging. Finally I made the move to oncology to give my compounds a chance to be tested in a more biological setting. I am now the public engagement manager in the Department of Oncology at the University of Oxford, where I look for opportunities to discuss our science with school students, adult audiences and people who have been touched by cancer. During my spare time, I am the Adventure Training Officer for Thames Valley RAF Air Cadets, where I work to provide opportunities to allow young people to experience hill walking, climbing, paddlesport, and trail cycling. I am a keen hill walker myself and recently, made it to 6000 m in the Himalayas.

Identifiants

pubmed: 29957072
doi: 10.2217/fon-2018-0138
doi:

Substances chimiques

Radioactive Tracers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2323-2325

Auteurs

Martin Christlieb (M)

Department of Oncology, Old Road Campus Research Bldg, Roosevelt Drive, Oxford OX3 7DQ, UK.

Roshaine Wijayatunga (R)

Future Science Group, Unitec House 2 Albert Place, Albert Pl, London N3 1QB, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH